Project leader

Prof. Sophia Frangou Phone: +1 (212) 659-1668 Fax: +1 (212) 659-8576 E-mail

Project staff

Institute presentation

Icahn School of Medicine at Mount Sinai is among the top medical schools in the United States. It is recognized as a national and international leader in biomedicine because of the expertise and commitment of the entire Mount Sinai community, from our world-class faculty to our outstanding students and trainees to our dedicated staff. A $2.25 billion strategic plan, with an emphasis on translational medicine, is positioning Icahn School of Medicine for ongoing success. The School has created 14 multidisciplinary research institutes to foster intensive collaboration along a continuum that runs from the laboratory through to patient care. As a result, recent recruits working side-by-side with established faculty are securing unprecedented levels of extramural funding for research and are expanding the volume and scope of our clinical practices. We have made major investments in high performance computing, computational biology, genomics, molecular pathology and imaging, along with the infrastructure to facilitate therapeutic discovery. Most importantly, Mount Sinai has created an environment of innovation and entrepreneurship to encourage our students and faculty to partner in challenging existing limitations of science and medicine in order to create and discover what was previously thought to be impossible. We enjoy a close relationship with The Mount Sinai Hospital, currently ranked among the nation's best hospitals, and the Mount Sinai Health System. Basic research and translational medicine discoveries on the Mount Sinai campus enable our physicians to take cutting edge approaches to the prevention and treatment of a wide variety of conditions.